This is the library for the Enduring Materials from the Targets for Cancer IO: A Deep Dive, TCR based therapies webinar that was conducted on December 7, 2022 . Date of Live Event: Wednesday, Dec. 7, 2022 – 2 p.m.–4 p.m. CST Moderators: Harlan Robins, PhD – Adaptive...
Targets in Cancer Immunotherapy_ A Deep Dive, TCR based Therapies.mp4
This webinar, the ninth and final session of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind natural killer cell engagers. Basic, clinical and translational researchers in academia and industry and members of the investment community are...
01-11-2023 | 10:00 - 12:00 CT
This webinar, the eighth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind therapies involving T cell receptors. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
12-07-2022 | 14:00 - 16:00 CT
This webinar, the seventh of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the enhanced blockade of cytotoxic T lymphocyte antigen-4 . Basic, clinical and translational researchers in academia and industry and members of the...
10-05-2022 | 13:00 - 15:00 CT
This webinar, the sixth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind induced pluripotent stem cell-derived cell therapies. Basic, clinical and translational researchers in academia and industry and members of the investment...
09-26-2022 | 10:00 - 12:00 CT
This webinar, the fifth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind B-cell modulation for anti-tumor immunity and reduction of ICI toxicity. Basic, clinical and translational researchers in academia and industry and members of the...
09-15-2022 | 12:00 - 14:00 CT
This webinar, the fourth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the targeted systemic delivery of innate immune activators. Basic, clinical and translational researchers in academia and industry and members of the investment...
08-26-2022 | 10:00 - 12:00 CT
This webinar, the third of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind tumor-infiltrating lymphocyte therapies. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
07-28-2022 | 12:00 - 14:00 CT
This is the library for the enduring materials from the Targets in Cancer IO: A Deep Dive, LAG 3 biology and Clinical Results webinar that took place on June 13, 2022. Moderators : Drew M. Pardoll, MD, PhD – Johns Hopkins University Dario A.A. Vignali, PhD – University of...
9 attachments
This webinar, the second of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind recombinant IL-18 immunotherapy. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target...
07-18-2022 | 12:00 - 14:00 CT
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us